The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Kim A. Margolin

City of Hope National Medical Center

Division of Medical Oncology and Therapeutics Research

1500 E. Duarte Road




Name/email consistency: high



  • City of Hope National Medical Center, Division of Medical Oncology and Therapeutics Research, 1500 E. Duarte Road, Duarte, USA. 2008
  • City of Hope National Medical Center, Duarte, California 91010-3000, USA. 2001 - 2007
  • Department of Medical Oncology and Therapeutics Research, City of Hope National Cancer Center, Duarte, CA 91010, USA. 2001 - 2005


  1. Cytokine therapy in cancer. Margolin, K. Expert. Opin. Biol. Ther (2008) [Pubmed]
  2. Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer. Margolin, K., Atkins, M.B., Dutcher, J.P., Ernstoff, M.S., Smith, J.W., Clark, J.I., Baar, J., Sosman, J., Weber, J., Lathia, C., Brunetti, J., Cihon, F., Schwartz, B. Clin. Cancer Res. (2007) [Pubmed]
  3. CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium. Margolin, K., Longmate, J., Baratta, T., Synold, T., Christensen, S., Weber, J., Gajewski, T., Quirt, I., Doroshow, J.H. Cancer (2005) [Pubmed]
  4. Mitotic rate and younger age as predictors of sentinel lymph node positivity. Margolin, K. Curr. Oncol. Rep (2005) [Pubmed]
  5. Molecular staging in stage II and III melanoma patients. Margolin, K. Curr. Oncol. Rep (2005) [Pubmed]
  6. Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer. Margolin, K.A., Doroshow, J.H., Frankel, P., Chow, W., Leong, L.A., Lim, D., McNamara, M., Morgan, R.J., Shibata, S., Somlo, G., Twardowski, P., Yen, Y., Kogut, N., Schriber, J., Alvarnas, J., Stalter, S. Biol. Blood Marrow Transplant. (2005) [Pubmed]
  7. Management of advanced germ cell cancer in patients with unfavorable prognosis. Margolin, K. J. Natl. Compr. Canc. Netw (2005) [Pubmed]
  8. Inhibition of vascular endothelial growth factor in the treatment of solid tumors. Margolin, K. Curr. Oncol. Rep (2002) [Pubmed]
  9. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. Margolin, K., Atkins, B., Thompson, A., Ernstoff, S., Weber, J., Flaherty, L., Clark, I., Weiss, G., Sosman, J., II Smith, W., Dutcher, P., Gollob, J., Longmate, J., Johnson, D. J. Cancer Res. Clin. Oncol. (2002) [Pubmed]
  10. Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data. Margolin, K., Gordon, M.S., Holmgren, E., Gaudreault, J., Novotny, W., Fyfe, G., Adelman, D., Stalter, S., Breed, J. J. Clin. Oncol. (2001) [Pubmed]
  11. Autologous and allogeneic high-dose therapy for melanoma. Margolin, K.A. Curr. Oncol. Rep (2001) [Pubmed]
  12. Dolastatin-10 in metastatic melanoma: a phase II and pharmokinetic trial of the California Cancer Consortium. Margolin, K., Longmate, J., Synold, T.W., Gandara, D.R., Weber, J., Gonzalez, R., Johansen, M.J., Newman, R., Baratta, T., Doroshow, J.H. Invest. New. Drugs (2001) [Pubmed]
  13. Methodologic guidelines for the design of high-dose chemotherapy regimens. Margolin, K., Synold, T., Longmate, J., Doroshow, J.H. Biol. Blood Marrow Transplant. (2001) [Pubmed]
WikiGenes - Universities